Variant report
Variant | esv15035 |
---|---|
Chromosome Location | chr4:132778707-132832771 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:33)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:33 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr4:132800279-132800515 | GM12878 | blood: | n/a | chr4:132800367-132800378 |
2 | BATF | chr4:132800260-132800528 | GM12878 | blood: | n/a | chr4:132800367-132800378 |
3 | BCL11A | chr4:132800227-132800577 | GM12878 | blood: | n/a | n/a |
4 | CEBPB | chr4:132790795-132790862 | HepG2 | liver: | n/a | chr4:132790812-132790829 chr4:132790815-132790826 |
5 | CTCF | chr4:132808642-132808705 | GM10266 | blood: | n/a | n/a |
6 | CTCF | chr4:132781362-132781400 | Lung_OC | lung: | n/a | n/a |
7 | FOXA1 | chr4:132797427-132797709 | HepG2 | liver: | n/a | n/a |
8 | GATA2 | chr4:132824216-132824465 | K562 | blood: | n/a | n/a |
9 | IRF4 | chr4:132800275-132800568 | GM12878 | blood: | n/a | n/a |
10 | MAFF | chr4:132794797-132794959 | K562 | blood: | n/a | n/a |
11 | MAFF | chr4:132827330-132827592 | HepG2 | liver: | n/a | chr4:132827439-132827457 |
12 | MAFK | chr4:132794777-132794959 | HepG2 | liver: | n/a | chr4:132794842-132794857 chr4:132794842-132794858 chr4:132794845-132794859 chr4:132794847-132794858 chr4:132794847-132794858 |
13 | MAFK | chr4:132827397-132827597 | IMR90 | lung: | n/a | chr4:132827542-132827557 chr4:132827442-132827453 |
14 | MAFK | chr4:132827367-132827580 | HepG2 | liver: | n/a | chr4:132827542-132827557 chr4:132827442-132827453 |
15 | MAFK | chr4:132794762-132794990 | HepG2 | liver: | n/a | chr4:132794842-132794857 chr4:132794842-132794858 chr4:132794845-132794859 chr4:132794847-132794858 chr4:132794847-132794858 |
16 | MAFK | chr4:132794788-132794801 | IMR90 | lung: | n/a | n/a |
17 | MAFK | chr4:132827340-132827605 | HepG2 | liver: | n/a | chr4:132827542-132827557 chr4:132827442-132827453 |
18 | PBX3 | chr4:132811991-132812144 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr4:132814368-132814465 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr4:132792647-132792761 | GM12878 | blood: | n/a | n/a |
21 | POU2F2 | chr4:132783029-132783359 | GM12878 | blood: | n/a | n/a |
22 | POU2F2 | chr4:132827963-132828283 | GM12878 | blood: | n/a | n/a |
23 | POU2F2 | chr4:132803640-132803968 | GM12878 | blood: | n/a | n/a |
24 | SIX5 | chr4:132831649-132831941 | GM12878 | blood: | n/a | n/a |
25 | SP1 | chr4:132820410-132820487 | HepG2 | liver: | n/a | n/a |
26 | SP1 | chr4:132807049-132807295 | GM12878 | blood: | n/a | n/a |
27 | SP1 | chr4:132811808-132812116 | GM12878 | blood: | n/a | n/a |
28 | SPI1 | chr4:132789165-132789297 | K562 | blood: | n/a | n/a |
29 | SRF | chr4:132810252-132810375 | GM12878 | blood: | n/a | n/a |
30 | STAT3 | chr4:132832119-132832230 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | STAT3 | chr4:132782155-132782327 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | TCF12 | chr4:132783087-132783284 | HepG2 | liver: | n/a | n/a |
33 | ZBTB33 | chr4:132803766-132804049 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL7AP28 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3961470 | chr4:132782162-132782163 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs171208 | chr4:132782202-132782203 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs60008863 | chr4:132782222-132782223 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs187073937 | chr4:132782260-132782261 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs189748683 | chr4:132782281-132782282 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs200871693 | chr4:132782320-132782321 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs367888177 | chr4:132782323-132782324 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs564311313 | chr4:132782324-132782325 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs62305991 | chr4:132783050-132783051 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs555587728 | chr4:132783065-132783066 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs688164 | chr4:132783068-132783069 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs572235546 | chr4:132783109-132783110 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs562288770 | chr4:132783214-132783215 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs62305992 | chr4:132783246-132783247 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs62305993 | chr4:132783285-132783286 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs633149 | chr4:132783294-132783295 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs558239296 | chr4:132783305-132783306 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs62305994 | chr4:132783324-132783325 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs577909444 | chr4:132783331-132783332 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs543430218 | chr4:132783336-132783337 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs551899778 | chr4:132792833-132792834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs3977689 | chr4:132792863-132792864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2863853 | chr4:132792903-132792904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2863854 | chr4:132792924-132792925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571346294 | chr4:132792936-132792937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569425138 | chr4:132792949-132792950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538075013 | chr4:132792953-132792954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2863855 | chr4:132792954-132792955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370310627 | chr4:132792961-132792962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184662153 | chr4:132792962-132792963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567233737 | chr4:132792973-132792974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536374106 | chr4:132792982-132792983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552690438 | chr4:132793009-132793010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572545431 | chr4:132793011-132793012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2863856 | chr4:132793027-132793028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544863771 | chr4:132793038-132793039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570350 | chr4:132793135-132793136 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs553628661 | chr4:132793143-132793144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190291469 | chr4:132793147-132793148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200336248 | chr4:132793155-132793156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2902592 | chr4:132793158-132793159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2863857 | chr4:132793162-132793163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544093257 | chr4:132793178-132793179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544850278 | chr4:132793179-132793180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561172630 | chr4:132793194-132793195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530117641 | chr4:132793204-132793205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201394262 | chr4:132793210-132793211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182512317 | chr4:132793226-132793227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560479609 | chr4:132793240-132793241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114178609 | chr4:132793259-132793260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:132792800-132793400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr4:132799600-132800800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:132799600-132800800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr4:132809400-132810200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:132821800-132822400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |